The European Medicines Agency has backed expanding Namuscla to address muscle rigidity in children and adolescents with rare inherited neuromuscular conditions.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/myotonia-drug-gets-green-light-pediatric-patients-eu-2026a10009si?src=rss
Author :
Publish date : 2026-03-31 13:13:00
Copyright for syndicated content belongs to the linked Source.
